265 related articles for article (PubMed ID: 20843992)
1. Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging.
Oto A; Kayhan A; Jiang Y; Tretiakova M; Yang C; Antic T; Dahi F; Shalhav AL; Karczmar G; Stadler WM
Radiology; 2010 Dec; 257(3):715-23. PubMed ID: 20843992
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of central gland prostate cancer from benign prostatic hyperplasia using monoexponential and biexponential diffusion-weighted imaging.
Liu X; Zhou L; Peng W; Wang C; Wang H
Magn Reson Imaging; 2013 Oct; 31(8):1318-24. PubMed ID: 23791546
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of prostate cancer and stromal hyperplasia in the transition zone with histogram analysis of the apparent diffusion coefficient.
Xiaohang L; Bingni Z; Liangping Z; Weijun P; Xiaoqun Y; Yong Z
Acta Radiol; 2017 Dec; 58(12):1528-1534. PubMed ID: 28286980
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score--a computer-aided diagnosis development study.
Peng Y; Jiang Y; Yang C; Brown JB; Antic T; Sethi I; Schmid-Tannwald C; Giger ML; Eggener SE; Oto A
Radiology; 2013 Jun; 267(3):787-96. PubMed ID: 23392430
[TBL] [Abstract][Full Text] [Related]
5. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.
Hoeks CM; Hambrock T; Yakar D; Hulsbergen-van de Kaa CA; Feuth T; Witjes JA; Fütterer JJ; Barentsz JO
Radiology; 2013 Jan; 266(1):207-17. PubMed ID: 23143029
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.
Vargas HA; Akin O; Franiel T; Mazaheri Y; Zheng J; Moskowitz C; Udo K; Eastham J; Hricak H
Radiology; 2011 Jun; 259(3):775-84. PubMed ID: 21436085
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-tensor MRI at 3 T: differentiation of central gland prostate cancer from benign prostatic hyperplasia.
Park SY; Kim CK; Park BK; Ha SY; Kwon GY; Kim B
AJR Am J Roentgenol; 2014 Mar; 202(3):W254-62. PubMed ID: 24555622
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.
Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA
Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy?
Donati OF; Jung SI; Vargas HA; Gultekin DH; Zheng J; Moskowitz CS; Hricak H; Zelefsky MJ; Akin O
Radiology; 2013 Aug; 268(2):440-50. PubMed ID: 23481164
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a logistic regression model to distinguish transition zone cancers from benign prostatic hyperplasia on multi-parametric prostate MRI.
Iyama Y; Nakaura T; Katahira K; Iyama A; Nagayama Y; Oda S; Utsunomiya D; Yamashita Y
Eur Radiol; 2017 Sep; 27(9):3600-3608. PubMed ID: 28289941
[TBL] [Abstract][Full Text] [Related]
11. Transition zone prostate cancer: incremental value of diffusion-weighted endorectal MR imaging in tumor detection and assessment of aggressiveness.
Jung SI; Donati OF; Vargas HA; Goldman D; Hricak H; Akin O
Radiology; 2013 Nov; 269(2):493-503. PubMed ID: 23878284
[TBL] [Abstract][Full Text] [Related]
12. Diffusion kurtosis imaging study of prostate cancer: preliminary findings.
Tamura C; Shinmoto H; Soga S; Okamura T; Sato H; Okuaki T; Pang Y; Kosuda S; Kaji T
J Magn Reson Imaging; 2014 Sep; 40(3):723-9. PubMed ID: 24924835
[TBL] [Abstract][Full Text] [Related]
13. Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging.
Huang W; Tudorica LA; Li X; Thakur SB; Chen Y; Morris EA; Tagge IJ; Korenblit ME; Rooney WD; Koutcher JA; Springer CS
Radiology; 2011 Nov; 261(2):394-403. PubMed ID: 21828189
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted imaging improves the diagnostic accuracy of conventional 3.0-T breast MR imaging.
Ei Khouli RH; Jacobs MA; Mezban SD; Huang P; Kamel IR; Macura KJ; Bluemke DA
Radiology; 2010 Jul; 256(1):64-73. PubMed ID: 20574085
[TBL] [Abstract][Full Text] [Related]
15. Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume.
Mazaheri Y; Hricak H; Fine SW; Akin O; Shukla-Dave A; Ishill NM; Moskowitz CS; Grater JE; Reuter VE; Zakian KL; Touijer KA; Koutcher JA
Radiology; 2009 Aug; 252(2):449-57. PubMed ID: 19703883
[TBL] [Abstract][Full Text] [Related]
16. Biexponential apparent diffusion coefficients values in the prostate: comparison among normal tissue, prostate cancer, benign prostatic hyperplasia and prostatitis.
Liu X; Peng W; Zhou L; Wang H
Korean J Radiol; 2013; 14(2):222-32. PubMed ID: 23483254
[TBL] [Abstract][Full Text] [Related]
17. Nonmalignant breast lesions: ADCs of benign and high-risk subtypes assessed as false-positive at dynamic enhanced MR imaging.
Parsian S; Rahbar H; Allison KH; Demartini WB; Olson ML; Lehman CD; Partridge SC
Radiology; 2012 Dec; 265(3):696-706. PubMed ID: 23033500
[TBL] [Abstract][Full Text] [Related]
18. Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?
Turkbey B; Shah VP; Pang Y; Bernardo M; Xu S; Kruecker J; Locklin J; Baccala AA; Rastinehad AR; Merino MJ; Shih JH; Wood BJ; Pinto PA; Choyke PL
Radiology; 2011 Feb; 258(2):488-95. PubMed ID: 21177390
[TBL] [Abstract][Full Text] [Related]
19. Cancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers.
Bhooshan N; Giger ML; Jansen SA; Li H; Lan L; Newstead GM
Radiology; 2010 Mar; 254(3):680-90. PubMed ID: 20123903
[TBL] [Abstract][Full Text] [Related]
20. Prostate Cancer: Diffusion-weighted MR Imaging for Detection and Assessment of Aggressiveness-Comparison between Conventional and Kurtosis Models.
Tamada T; Prabhu V; Li J; Babb JS; Taneja SS; Rosenkrantz AB
Radiology; 2017 Jul; 284(1):100-108. PubMed ID: 28394755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
